Bácskay, I.; Arany, P.; Fehér, P.; Józsa, L.; Vasvári, G.; Nemes, D.; Pető, Á.; Kósa, D.; Haimhoffer, Á.; Ujhelyi, Z.;
et al. Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review. Pharmaceutics 2025, 17, 148.
https://doi.org/10.3390/pharmaceutics17020148
AMA Style
Bácskay I, Arany P, Fehér P, Józsa L, Vasvári G, Nemes D, Pető Á, Kósa D, Haimhoffer Á, Ujhelyi Z,
et al. Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review. Pharmaceutics. 2025; 17(2):148.
https://doi.org/10.3390/pharmaceutics17020148
Chicago/Turabian Style
Bácskay, Ildikó, Petra Arany, Pálma Fehér, Liza Józsa, Gábor Vasvári, Dániel Nemes, Ágota Pető, Dóra Kósa, Ádám Haimhoffer, Zoltán Ujhelyi,
and et al. 2025. "Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review" Pharmaceutics 17, no. 2: 148.
https://doi.org/10.3390/pharmaceutics17020148
APA Style
Bácskay, I., Arany, P., Fehér, P., Józsa, L., Vasvári, G., Nemes, D., Pető, Á., Kósa, D., Haimhoffer, Á., Ujhelyi, Z., & Sinka, D.
(2025). Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: A Review. Pharmaceutics, 17(2), 148.
https://doi.org/10.3390/pharmaceutics17020148
